Asrij is an endocytic protein expressed in mouse embryonic stem cells (mESCs) and is essential for maintenance of stemness of mESCs (Mukhopadhyay et al., 2003; Sinha et al., 2013) . Its human ortholog named Ovarian Carcinoma Immuno-reactive Antigen domain containing protein 1 (OCIAD1) is 85% identical. We ectopically expressed Asrij in epiblast stage equivalent-human embryonic stem cells (hESCs) to test for induction of naive pluripotency in primed pluripotent cells. The construct pCAG-Asrij was introduced into hESCs by microporation. Ectopic expression of Asrij in BJNhem20 hESC line was performed by selecting for plasmid transfection, followed by stable cell line generation.
Resource details
BJNhem20-Asrij line was generated by transfection of BJNhem20 human embryonic stem cells (hESCs) with pCAG-Asrij construct using microporation technique with the conditions of 1100 V, 30 ms pulse width and 1 pulse. The pCAG-Asrij construct was generated by cloning Asrij Open Reading Frame amplicon from amino acids 1-247 between Xho1 and Not1 sites using appropriate primers. A stable hESC line was generated after subjecting these transfected cells to puromycin selection for two weeks.
Ectopic Asrij expression was validated by immunostaining and Western blotting in three biological replicates.
Expression of pluripotent stem cell markers OCT4, SSEA3/4 and TRA1-81 has been shown by immunostaining. Differentiation of these hESC lines to all the three germ layers was demonstrated by immunostaining for different markers such as AFP (endoderm), Brachyury (mesoderm) and β-III tubulin (ectoderm).
Materials and methods

Cell culture
hESC line BJNhem20 was derived from discarded Grade III embryos and tested for pluripotency (Inamdar et al., 2009 ). This cell line has been cultured continuously for over 200 passages without acquiring any karyotypic abnormality (Venu et al., 2010) 
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Stem Cell Research j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / s c r Technologies Cat no.10828-028), 1% GlutaMAX (Life Technologies Cat no.35050-061), 1% non-essential amino acids (MEM-NEAA-Life Technologies Cat no.11140-050), 0.1% β-mercaptoethanol (Life Technologies Cat no.21985-023) and 8 ng/ml human recombinant basic fibroblast growth factor (human bFGF-Sigma Aldrich Pvt. Ltd. Cat no. F-0291). These cells were routinely passaged by mechanical cutting of undifferentiated colonies.
Microporation of hESCs to generate BJNhem20-Asrij cell line
For microporation, BJNhem20 cells were grown on Matrigel (Becton Dickinson Catalog No. 354277) coated dishes till they were 70% confluent. The cells were trypsinized with 1X TrypLE (Life Technologies Cat No.12605-010) at 37°C for 4 min. The cells were pelleted by centrifugation at 1000 rpm for 2 min and washed with phosphate buffered saline and enumerated. 0.5 million cells were resuspended in 10 μl of R buffer and 6 μg of DNA was mixed and the cells were transfected in a microporator (NeonMicroporation Kit-Life Technologies Cat no. MPK1096). Microporation conditions used were 1100 V, 30 ms and 1 pulse according to the manufacturer's instructions. The cells were then directly seeded onto Matrigel-coated dishes with mTESR media (Stem Cell Technologies Cat no. 05850) supplemented with ROCK inhibitor (10 μM Y-27632, Sigma Aldrich Pvt. Ltd. Cat no. Y0503) to aid the survival of single cells. mTESR medium without ROCK inhibitor was used after 12-16 h when the cells adhered. 48 h after transfection, puromycin (0.5 μg/ml Sigma Aldrich Pvt. Ltd. P8833) was added to the transfected culture and selection was continued for 2 weeks. Puromycin resistant individual clones of transgenic Asrij overexpressing hESCs were manually picked and passaged. BJNhem20-Asrij cells were subsequently cultured in both feeder free conditions on matrigel in the presence of mTESR medium and on feeders with regular hESC medium.
Embryoid body differentiation
Differentiation of embryoid bodies was carried out as described before (Inamdar et al., 2009) . Briefly, colonies grown on MEFs were mechanically cut and pieces cultured in human embryoid body media (10% FBS-Hyclone-SH30070 with β-mercaptoethanol and GlutaMAX in DMEM) on low attachment plates. These hESC aggregates were allowed to grow in suspension for 3 days after which the colonies formed embryoid body-like structures and were transferred to the tissue culture dishes pre-treated with 0.1% gelatin and allowed to attach and differentiate spontaneously till the time for harvest from day 6 onwards for immunostaining analyses.
Immunostaining hESC and hEBs were fixed in 2% paraformaldehyde (in PBS), permeabilized with Triton-X-100 (0.1% for cells and 0.3% for EBs) and then blocked with 4% FBS for 1 h at RT (Room Temperature). Post blocking, cells were incubated with the appropriate primary antibodies overnight at 4°C, then were washed with PBS at RT and incubated with secondary antibody conjugated to either Alexa Fluor 488 or 568 for 1 h at RT (Dilution 1:400 Invitrogen). The cells were washed and stained using DAPI (1:500 in M1 buffer Invitrogen) to visualize nuclei. The images were acquired using an epifluorescence microscope (IX-81 microscope system (Olympus)) fitted with a cooled CCD camera (CoolSnap, Roper Scientific 
Western blot
For Western blot analysis, cells were pelleted, washed with 1X PBS, lysed in lysis buffer for 4 h at 4°C and clarified by centrifugation at 10,000 rpm for 20 min at 4°C. Total protein was estimated using Bradford reagent and 40 μg of lysate was loaded on a 12% SDS-PAGE gel. The gel was electro-blotted onto Nitrocellulose membrane (PALL corporation, USA) and incubated with primary antibody OCIAD1 (Abcam; Cat no., ab91574) at 4°C (overnight), washed, then probed with appropriate HRP-conjugated secondary antibody (Bangalore Genei) for 1 h at RT and developed using ECL chemiluminescence kit (Thermo Scientific, Rockford, IL, US).
